表纸
市场调查报告书

北美的癌症诊断市场:销售额预测,市场策略,供应商的市场占有率 - 新肿瘤标记(癌症筛检)·技术·市场机会

2020 North America Tumor Markers Sales Segment Forecasts: USA, Canada, Mexico--Supplier Shares and Strategies, Emerging Tests and Technologies

出版商 Venture Planning Group 商品编码 445423
出版日期 内容资讯 英文 630 Pages
商品交期: 最快1-2个工作天内
价格
北美的癌症诊断市场:销售额预测,市场策略,供应商的市场占有率 - 新肿瘤标记(癌症筛检)·技术·市场机会 2020 North America Tumor Markers Sales Segment Forecasts: USA, Canada, Mexico--Supplier Shares and Strategies, Emerging Tests and Technologies
出版日期: 内容资讯: 英文 630 Pages
简介

本报告提供北美各国 (美国·加拿大·墨西哥) 癌症诊断检验 (肿瘤标记(癌症筛检)检验等)的市场相关分析,提供您诊断方法概要和目前技术水准,目前主要诊断药·检验手法,各国·各诊断手法趋势预测 (今后5年份),主要供应商简介·产品系列·产业策略,今后的市场机会等调查评估。

目录·图表一览

各国市场趋势

  • 加拿大
  • 墨西哥
  • 美国

肿瘤标记(癌症筛检)的分类

各种癌症/肿瘤标记(癌症筛检)诊断药的开发·上市情形

  • ACTH检验
  • AFP检验
  • β-2微球蛋白检验
  • CA 15-3/27.29检验
  • CA 19-9检验
  • CA-125检验
  • 抑钙素检验
  • CEA检验
  • 雌激素受体检验
  • 孕激素受体检验
  • 含铁蛋白检验
  • 胃泌素检验
  • HCG检验
  • 胰岛素检验
  • NSE检验
  • 潜血检验
  • 子宫颈抹片/人类乳突病毒(HPV)检验
  • PAP检验
  • PSA检验
  • 淋巴球的细分类检验

癌症诊断上潜在的可利用性

  • 生化标帜物
  • 致癌遗传基因
  • 成长因素
  • 细胞聚落刺激因子
  • 淋巴激素
  • 免疫组织化学染色

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录
Product Code: VP41892

This new 3-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test.

This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic testing market, in evaluating emerging opportunities and developing effective business strategies during the next five years.

The report provides granular market segmentation analysis and forecasts for over 40 tumor markers; profiles leading suppliers and recent market entrants with innovative technologies and products; reviews current and emerging assays; reviews current instrumentation; evaluates emerging technologies; and offers specific opportunities and growth strategies for suppliers.

Rationale

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.

Country Analyses

Canada, Mexico, USA

Business Opportunities and Strategic Recommendations

- Specific new product development opportunities with potentially significant market appeal during the next five years.

- Design criteria for new products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Over 200 Current and Emerging Cancer Diagnostic Tests

- Oncogenes - Biochemical Markers - Growth Factors - Colony Stimulating Factors - Hormones - Immunohistochemical Stains - Lymphokines

- ACTH, AFP, Beta-2 Microglobulin, CA 15-3/27.29, CA 19-9, CA 125, Calcitonin, Cathepsin, CEA, Chromogranin, Colon-Specific Antigen, Cytokeratins, Estrogen Receptor, Ferritin, Gastrin, HCG, Insulin, Interferons, Interleukins, Lymphocyte Subtyping, Neuron-Specific Enolase, Nucleolar, Occult Blood, Oncogenes, Pancreatic Oncofetal Antigen, Pap Smear, Parathyroid Hormone, Progesterone Receptor, Prostatic Acid Phosphatase, Prostatic Specific Antigen, S-100 Protein, Serotonin, Sialic Acid, Squamous Cell Carcinoma Ag, TDT, Thymidine Kinase, Thyroglobulin, Tissue Polypeptide Antigen, and others.

Supplier Shares, Sales and Volume Forecasts

- Sales and market shares of major cancer diagnostic product suppliers in major countries by individual test.

- Five-year test volume and sales forecasts for major cancer diagnostic assays.

Instrumentation Review

- Analysis of major molecular diagnostic and immunodiagnostic analyzers used for cancer testing, including their operating characteristics, features and selling prices.

Technology Assessment

- Assessment of latest technologies and their potential applications for cancer diagnostic testing.

- Review of competing/complementing technologies.

- Companies, universities and research centers developing new cancer diagnostic tests and detection technologies.

Competitive Strategies

- Strategic assessments of major suppliers and start-up firms developing innovative cancer diagnostic technologies and products, including their sales, product portfolios, marketing tactics, collaborative arrangements, and new products in R&D.

- The companies analyzed in the report include:

- Abbott Agilent Technologies Applied Gene Technologies Arca Biopharma Beckman Coulter/Danaher Becton Dickinson bioMerieux Bio-Rad CellSearch Cepheid Clinical Genomics Decode Genetics DiaSorin Diazyme Eiken Chemical Elitech Group Enzo Biochem Epigenomics Exact Sciences Fujirebio Guided Therapeutics Hologic Janssen Diagnostics Leica Biosystems Kyowa Medex Myriad Genetics OncoLab Ortho-Clinical Diagnostics Panacea Pharmaceuticals PerkinElmer Polymedco Qiagen Quest Diagnostics Roche Scienion Sequenom Siemens Healthineers Takara Bio Theradiag Thermo Fisher Tosoh Vermillion Wako Pure Chemicals

Contains 630 pages and 107 tables

Table of Contents

List of Tables

  • Canada Cancer Diagnostic Volume Forecasts by Test
  • Canada Cancer Diagnostics Sales Forecasts by Test
  • Mexico Cancer Diagnostic Volume Forecasts by Test
  • Mexico Cancer Diagnostics Sales Forecasts by Test
  • U.S.A. Executive Summary Table: Total Tumor Marker Test Volume and Sales Forecast by Market Segment
  • U.S.A., Estimated New Cancer Cases and Deaths
  • U.S.A., Estimated Cancer Death Rates Per 100,000 Population
  • U.S.A., Laboratories Performing Tumor Marker Tests by Market Segment
  • U.S.A., Hospital Laboratories Performing Tumor Marker Tests by Bed Size
  • U.S.A., Commercial/Private Laboratories Performing Tumor Marker Tests by Annual Test Volume
  • U.S.A., Physician Office Laboratories Performing Tumor Marker Tests by Practice Size
  • U.S.A., Total Tumor Marker Test Volume Forecast by Market Segment
  • U.S.A., All Market Segments Major Tumor Marker Test Volume Forecast
  • U.S.A., Hospital Laboratories Major Tumor Marker Test Volume Forecast by Test
  • U.S.A., Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast
  • U.S.A., Physician Offices/Group Practices Major Tumor Marker Test Volume Forecast
  • U.S.A., Cancer Clinics Major Tumor Marker Test Volume Forecast by Test
  • U.S.A., Total Tumor Marker Sales Forecast by Market Segment
  • U.S.A., All Market Segment Major Tumor Marker Sales Forecast by Test
  • U.S.A., Hospital Laboratories Major Tumor Marker Sales Forecast by Test
  • U.S.A., Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
  • U.S.A., Physician Offices/Group Practices Major Tumor Marker Sales Forecast by Test
  • U.S.A., Cancer Clinics Major Tumor Marker Sales Forecast by Test
  • U.S.A., ACTH Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., AFP Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., CA 15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., CA 19-9 Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., CA-125 Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., Cathepsin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., CEA Test Volume and Diagnostics Sales by Market Segment
  • U.S.A., Chromogranin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., Colon-specific Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., HCG Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., Interferons Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., Interleukins Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., NSE Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., Nucleolar Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., PAP Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., PSA Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., S-100 Protein Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., TDT Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., TPA Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., Total Tumor Marker Sales by Major Supplier
  • U.S.A., ACTH Testing Market Diagnostics Sales by Major Supplier
  • U.S.A., AFP Testing Market Diagnostics Sales by Major Supplier
  • U.S.A., Beta-2 Migroblolulin Testing Market Diagnostics Sales by Major Supplier
  • U.S.A., CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier
  • U.S.A., CA 19-9 Testing Market Diagnostics Sales by Major Supplier
  • U.S.A., CA 125 Testing Market Diagnostics Sales by Major Supplier
  • U.S.A., CEA Testing Market Diagnostics Sales by Major Supplier
  • U.S.A., Ferritin Testing Market Diagnostics Sales by Major Supplier
  • U.S.A., HCG Testing Market Diagnostics Sales by Major Supplier
  • U.S.A., Insulin Testing Market Diagnostics Sales by Major Supplier
  • U.S.A., Parathyroid Hormone Testing Market Diagnostics Sales by Major Supplier
  • U.S.A., PAP Testing Market Diagnostics Sales by Major Supplier
  • U.S.A., Progesterone Receptor Testing Market Diagnostics Sales by Major Supplier
  • U.S.A., PSA Testing Market Diagnostics Sales by Major Supplier
  • Tumor Marker Classification
  • Major Companies Developing or Marketing ACTH Tests
  • Major Companies Developing or Marketing AFP Tests
  • Major Companies Developing or Marketing Beta-2 Microglobulin Tests
  • Major Companies Developing or Marketing CA 15-3/27.29 Tests
  • Major Companies Developing or Marketing CA 19-9 Tests
  • Major Companies Developing or Marketing CA 125 Tests
  • Major Companies Developing or Marketing Calcitonin Tests
  • Major Companies Developing or Marketing CEA Tests
  • Major Companies Developing or Marketing Estrogen Receptor Tests
  • Major Companies Developing or Marketing Progesterone Receptor Tests
  • Major Companies Developing or Marketing Ferritin Tests
  • Major Companies Developing or Marketing Gastrin Tests
  • Major Companies Developing or Marketing HCG Tests
  • Major Companies Developing or Marketing Insulin Tests
  • Major Companies Developing or Marketing NSE Tests
  • Major Companies Developing or Marketing Occult Blood Tests
  • Major Companies Developing or Marketing PAP Smear/HPV Tests
  • Major Companies Developing or Marketing PAP Tests
  • Major Companies Developing or Marketing PSA Tests
  • Major Companies Developing or Marketing
  • Lymphocyte Subclassification Tests
  • Biochemical Markers Potential Applications In Cancer Diagnosis
  • Oncogenes Potential Applications In Cancer Diagnosis
  • Major Companies Developing or Marketing Oncogene Tests
  • Growth Factors Potential Applications In Cancer Diagnosis
  • Colony Stimulating Factors Potential Applications in Cancer Diagnosis
  • Lymphokines Potential Applications in Cancer Diagnosis
  • Immunohistochemical Stains Potential Applications in Cancer Diagnosis